Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

AMMONIA N 13

AMMONIA N-13

Standard Dose
3.75-260mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview AMMONIA N 13 is listed in Drugs@FDA under application 204539 (ANDA).

Marketing status: Discontinued Active ingredient AMMONIA N-13 Form and strength INJECTABLE;INTRAVENOUS - 3.75-260mCi/ML Sponsor CENTRAL RADIOPHARM Submission history Latest submission status date: 2015-06-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMMONIA N 13 is listed in Drugs@FDA under application 204539 (ANDA). Marketing status: Discontinued Active ingredient AMMONIA N-13 Form and strength INJECTABLE;INTRAVENOUS - 3.75-260mCi/ML Sponsor CENTRAL RADIOPHARM Submission history Latest submission status date: 2015-06-23 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
AMMONIA N 13 (AMMONIA N-13) | Drug Monograph | MedicHelpline